Skip to content
ProAct Trends LP hero

The pace of change across the pharmaceutical landscape shows no signs of slowing. From the continued growth of specialty medications and GLP-1 therapies to evolving biosimilar adoption and increased regulatory scrutiny, brokers, TPAs, and plan sponsors are navigating a complex and increasingly high stakes environment.

Join us for an exclusive 2-part webinar featuring a clear, data driven view of the trends impacting prescription drug spend today, along with practical insight into what plan sponsors should be preparing for next.

If you play a role in managing pharmacy benefits, you can't afford to miss these essential insights.

Drug Trend Insights

July 23, 2026  |  1:00-1:30pm ET

Pipeline Insights: Looking Ahead

August 19, 2026  |  2:00-2:30pm ET


Meet the Presenter

About Us

Deb Dempsey-1
 

Deborah Dempsey,
MBA, PharmD, RPh, Chief Operating Officer

Deborah has been a valued ProAct employee owner since March of 2019 and serves as our Chief Operating Officer. She is responsible for all PBM commercial operations including clinical services, implementation, benefit changes, group eligibility, our ProActPLUS program, mail order pharmacy services, and overall client experience.
 
Deborah received her Doctor of Pharmacy degree from Albany College of Pharmacy in 2007 and her MBA with a focus in healthcare from Utica University in 2020.  She has received the coveted Ownership Excellence Award from her peers at ProAct in 2020 as well as the Quest for Excellence Award in 2022. 

ProAct is an employee-owned pharmacy benefit manager providing prescription drug benefits since 1999. We manage the dispensing of prescription drugs through our mail order pharmacy and through our national retail network. Guided by employee ownership values, it is our mission to create and promote lasting partnerships built on value, transparency, and evidence-based pharmacy benefit management solutions.

ProAct's annual Drug Trend Report provides insights on important pharmacy industry trends and how our employee-owned organization has effectively managed the drug spend of our plan sponsors through data-driven program offerings and client-focused strategies. ProAct’s approach to controlling the spend of high-cost specialty medications by leveraging cost-efficient biosimilars, as well as our strategic approach to controlling GLP-1 agonist expenditures through evidence-based clinical criteria, ensures optimal therapeutic outcomes while prioritizing affordability.

As new state and federal legislation related to the pharmacy benefit and drug industry are introduced, ProAct is committed to continued proactive monitoring of regulatory changes that could affect our plan sponsors, and are prepared to adapt to safeguard the interests of those in which we partner.

Our dedicated employee owners are always available to you and your organizations to provide the resources, information, and support you need.